Ardea Biosciences, Inc. Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
11/6/2009 10:27:29 AM
More...
|
Ardea Biosciences, Inc. to Present at Three Upcoming Investor Conferences
10/28/2009 8:55:50 AM
More...
|
Ardea Biosciences, Inc. Announces Additional Positive Results from a Phase 2a Study of RDEA594 at the 2009 ACR/ARHP Annual Scientific Meeting
10/19/2009 9:09:29 AM
More...
|
Ardea Biosciences, Inc. to Present Results from a Phase 2a Study of RDEA594 at the 2009 ACR/ARHP Annual Scientific Meeting
9/30/2009 8:30:13 AM
More...
|
Ardea Biosciences, Inc. to Present at Three Upcoming Investor Conferences
9/16/2009 8:52:23 AM
More...
|
Ardea Biosciences, Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2009
8/27/2009 8:50:19 AM
More...
|
Ardea Biosciences, Inc. Reports Recent Accomplishments and Announces Second Quarter and Year-to-Date 2009 Financial Results
8/7/2009 8:23:52 AM
More...
|
Ardea Biosciences, Inc. Initiates Phase 2b Clinical Trial of RDEA594, Lead Product Candidate for the Treatment of Gout
7/20/2009 9:27:01 AM
More...
|
Ardea Biosciences, Inc. to Present at the 4th Annual Piper Jaffray Europe Conference
6/18/2009 8:32:28 AM
More...
|
Ardea Biosciences, Inc. Announces Positive Interim Phase 2a Results for Lead Gout Drug, RDEA594
6/11/2009 8:54:11 AM
More...
|
|